Sabra Health Care REIT (SBRA) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
24 Apr, 2026Executive summary
Annual meeting scheduled for June 17, 2026, at company headquarters in Tustin, CA.
Shareholders are invited to vote on director elections, auditor ratification, and executive compensation.
Voting can be done online, by mail, or in person at the meeting.
Voting matters and shareholder proposals
Election of seven directors is proposed, with all nominees recommended by the board.
Ratification of PricewaterhouseCoopers LLP as independent auditor for fiscal year ending December 31, 2026.
Advisory vote on executive compensation for named executive officers.
Other business may be transacted as may properly come before the meeting.
Board of directors and corporate governance
Seven director nominees listed: Craig A. Barbarosh, Katie Cusack, Michael J. Foster, Lynne S. Katzmann, Ann Kono, Jeffrey A. Malehorn, Richard K. Matros.
Board recommends voting in favor of all director nominees.
Latest events from Sabra Health Care REIT
- Q2 2026 delivered strong investment and NOI growth, but a net loss from a major loan write-off.SBRA
Q2 2026 - Q1 2026 saw strong earnings, robust investments, and reaffirmed guidance for continued growth.SBRA
Q1 2026 - Proxy covers director elections, auditor ratification, and performance-based executive pay.SBRA
Proxy filing - Q4 2025 saw strong managed senior housing growth and robust 2026 guidance for ~5% FFO/AFFO growth.SBRA
Q4 2025 - Director elections, auditor ratification, and executive pay highlight strong governance and ESG.SBRA
Proxy Filing - Annual meeting to vote on directors, executive pay, and auditor ratification, all board-backed.SBRA
Proxy Filing - Q3 2024 saw strong earnings, raised guidance, and robust liquidity amid sector growth.SBRA
Q3 2024 - 2024 guidance raised as managed senior housing and FFO/AFFO growth accelerate.SBRA
Q2 2024 - Q4 2024 saw strong managed senior housing growth, improved leverage, and a positive 2025 outlook.SBRA
Q4 2024